From byte to bench to bedside: molecular dynamics simulations and drug discovery
- PMID: 38155355
- PMCID: PMC10755930
- DOI: 10.1186/s12915-023-01791-z
From byte to bench to bedside: molecular dynamics simulations and drug discovery
Abstract
Molecular dynamics (MD) simulations and computer-aided drug design (CADD) have advanced substantially over the past two decades, thanks to continuous computer hardware and software improvements. Given these advancements, MD simulations are poised to become even more powerful tools for investigating the dynamic interactions between potential small-molecule drugs and their target proteins, with significant implications for pharmacological research.
Conflict of interest statement
The authors declare that they have no competing interests.
Update of
-
From Byte to Bench to Bedside: Molecular Dynamics Simulations and Drug Discovery.ArXiv [Preprint]. 2023 Nov 28:arXiv:2311.16946v1. ArXiv. 2023. Update in: BMC Biol. 2023 Dec 29;21(1):299. doi: 10.1186/s12915-023-01791-z. PMID: 38076508 Free PMC article. Updated. Preprint.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
